Cerus Corporation Total Current Liabilities 2011-2026 | CERS

Annual Total Current Liabilities Cerus Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
101 M	63.6 M	67.5 M	117 M	78.6 M	60 M	50.3 M	52.7 M	23.1 M	26.9 M	21.9 M	29.2 M	39.4 M	25.6 M	21.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
117 M	21.1 M	51.9 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	6.4 M	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	3.56 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	100 M	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
Alpine Immune Sciences ALPN	42 M	-	-	$ 2.17 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	47.5 M	-	-	$ 269 M	USA
Galera Therapeutics GRTX	645 K	-	-32.59 %	$ 7.61 M	USA
CRISPR Therapeutics AG CRSP	149 M	$ 49.8	-0.86 %	$ 4.48 B	Schweiz
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	9.38 M	-	-	$ 231 M	USA
Berkeley Lights BLI	45.5 M	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	51 M	$ 31.27	4.37 %	$ 2.08 B	USA
Generation Bio Co. GBIO	35.1 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	7.54 M	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	1.33 M	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	31 M	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	221 M	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	21.9 M	$ 14.72	-	$ 211 M	USA
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Enlivex Therapeutics Ltd. ENLV	9.02 M	$ 0.67	-6.8 %	$ 30.6 M	Israel
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	1.61 M	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	2.73 M	$ 2.84	-0.35 %	$ 4.68 M	Israel
Forte Biosciences FBRX	20.8 M	$ 17.56	0.92 %	$ 227 M	USA
Esperion Therapeutics ESPR	301 M	$ 3.15	-	$ 655 M	USA
Aptose Biosciences APTO	9.31 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	6.29 M	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	45.3 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	9.71 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	17.8 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	130 M	$ 24.38	-0.85 %	$ 3.1 B	USA